Dow Jones

42,840.26

1.18%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

UCB

UCB (UCB)

UCB SA

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:EU:UCB

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
19/11/2024	00:00	GlobeNewswire Inc.	Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity	EU:UCB	UCB SA
24/09/2024	00:00	GlobeNewswire Inc.	UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus and are Initiating Second Phase 3 Study in 2024	EU:UCB	UCB SA
22/03/2024	01:00	GlobeNewswire Inc.	UCB Convening Notice to the General Meeting of the Shareholders 2024	EU:UCB	UCB SA
22/03/2024	01:00	GlobeNewswire Inc.	UCB Convocation à l'Assemblée Générale des Actionnaires 2024	EU:UCB	UCB SA
24/05/2023	08:25	GlobeNewswire Inc.	ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery	EU:UCB	UCB SA
24/03/2023	01:30	GlobeNewswire Inc.	UCB Convening Notice to the General Meeting of theShareholders 2023	EU:UCB	UCB SA
24/03/2023	01:30	GlobeNewswire Inc.	UCB Convocation à L’ Assemblée Générale des Actionnaires 2023	EU:UCB	UCB SA
13/12/2022	15:01	GlobeNewswire Inc.	Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration	EU:UCB	UCB SA
25/03/2022	01:00	GlobeNewswire Inc.	UCB SA - CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES 2022	EU:UCB	UCB SA
25/03/2022	01:00	GlobeNewswire Inc.	UCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022	EU:UCB	UCB SA
26/03/2021	01:00	GlobeNewswire Inc.	UCB SA - convocation à l'assemblée générale ordinaire	EU:UCB	UCB SA
26/03/2021	01:00	GlobeNewswire Inc.	UCB SA/NV - Convening notice annual shareholders meeting	EU:UCB	UCB SA
27/03/2020	01:00	GlobeNewswire Inc.	UCB SA : Convocation à l'assemblée générale des actionnaires	EU:UCB	UCB SA
27/03/2020	01:00	GlobeNewswire Inc.	UCB SA/NV : Convening notice to the general meeting of shareholders	EU:UCB	UCB SA
22/03/2019	01:00	GlobeNewswire Inc.	UCB SA : Convocation à l'assemblée générale des actionnaires qui se tiendra à Bluepoint Brussels	EU:UCB	UCB SA
22/03/2019	01:00	GlobeNewswire Inc.	UCB SA/NV: Convening Notice to attend the general meeting of shareholders to be held at Bluepoint Brussels	EU:UCB	UCB SA
23/10/2018	00:00	GlobeNewswire Inc.	UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus	EU:UCB	UCB SA
20/04/2018	06:55	Cercle Finance	UCB: met la main sur un antiépileptique	EU:UCB	UCB SA
22/02/2018	07:42	Cercle Finance	UCB: bien orienté après des résultats solides	EU:UCB	UCB SA
06/11/2017	15:01	GlobeNewswire Inc.	Dermira and UCB Agree to End Collaboration Agreement for CIMZIA	EU:UCB	UCB SA
14/09/2017	07:00	GlobeNewswire Inc.	New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) Congress	EU:UCB	UCB SA
25/07/2017	00:00	GlobeNewswire Inc.	UCB and Dermira Announce U.S. and EU Regulatory Submissions for CIMZIA® (certolizumab pegol) for the treatment of Moderate-t...	EU:UCB	UCB SA
23/05/2017	10:57	Cercle Finance	UCB: poursuit son repli après le problème d'essai clinique.	EU:UCB	UCB SA
22/05/2017	04:07	Cercle Finance	UCB: plonge après des problèmes sur son Evenity.	EU:UCB	UCB SA
19/01/2017	01:00	GlobeNewswire Inc.	Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic...	EU:UCB	UCB SA
11/01/2017	05:11	Cercle Finance	UCB: bien orienté, un analyste en soutien.	EU:UCB	UCB SA
08/12/2016	01:00	GlobeNewswire Inc.	Second CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Ch...	EU:UCB	UCB SA
15/08/2016	04:27	Cercle Finance	UCB: salué pour une décision de justice aux Etats-Unis.	EU:UCB	UCB SA
25/04/2016	07:54	Cercle Finance	UCB: hausse de 11% du CA au 1er trimestre.	EU:UCB	UCB SA
08/03/2016	07:56	Cercle Finance	UCB: miné par une dégradation de broker.	EU:UCB	UCB SA